Hepatology
Conference Coverage
Living liver donation safety supported in single-center study
SCOTTSDALE, ARIZ. - A study has confirmed the finding of previous investigations that living liver donation yielded a low rate of severe...
Conference Coverage
Statin didn’t slow hepatic steatosis in HIV patients
SAN DIEGO – HIV patients taking a statin saw greater hepatic steatosis progression than did placebo patients.
Conference Coverage
Clinical hepatology debrief wraps up 2017 Liver Meeting
Kris V. Kowdley, MD, highlighted notable research presented at the meeting.
Conference Coverage
Emerging oral agent reduces ALT in NAFLD
In phase 2 dose-finding study, hepatic fraction decreased in treated patients.
Conference Coverage
Novel metabolite may be key in NAFLD
The gut microbiome–derived metabolite may be a useful biomarker.
Conference Coverage
Hispanics bear brunt of NAFLD disease burden
Relative risk of NAFLD is higher in Hispanics, but the risk of death from NAFLD is highest in whites.
Conference Coverage
Carvedilol fails to reduce variceal bleeds in acute-on-chronic liver failure
Some improvement seen at 28 days in acute kidney injury, sepsis.
Latest News
New biomarkers improve DILI predictability
WASHINGTON – Particular biomarkers and combinations can assess inflammation and mode of hepatocyte death.
Conference Coverage
Asians have highest rate of herbal dietary supplement DILI liver transplantations
Are herbal supplements more popular with Asian patients?
Conference Coverage
Early liver transplant good for patients with severe alcoholic hepatitis
Return to alcohol consumption is one possible hazard.
From the Journals
Targeted strategies better for birth cohort HCV testing
Primary care can generate follow-through with targeted testing.